Summary
- Current Price
- As of today, INBX price is $68.74, down -0.81% on
- Current Price All-Time High
- INBX price is currently -27.31% below its historical high of $94.57 set on
- Market Cap
- INBX current market cap is $1,000M, up +388.07% over the past 365 days
- PE Ratio
- INBX PE ratio is unknown
- Revenue
- INBX current annual revenue is $200.00K, down -88.89% year-over-year
- Next Earnings
- The next earnings release for INBX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Inhibrx Biosciences, Inc. |
| Ticker | NASDAQ: INBX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | inhibrx.com |
| Employees | 156 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $68.74 | |
| Price, 1D Change | -0.81% | |
| $1,000M | ||
| - | ||
| - | ||
| 1.02 | ||
| $200K | ||
| Revenue, 1Y Change | -88.89% | |
| $116.58 | ||
| EPS, 1Y Change | +799.19% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | INXBV | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $116.58 | ||
| EPS Estimate | -$9.01 | |
| EPS Est. Change | -107.73% | |
| $200.00K | ||
| Revenue Estimate | $1.30M | |
| Revenue Est. Change | +550.00% | |
| Current Price | $68.74 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.39 | -$16.67 | -279.80% | |
| $111.60 | $116.58 | +4.47% | |
| -$9.01 | N/A | -107.73% | |
| -$4.76 | N/A | -104.08% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $250.00K | $1.80M | +620.00% | |
| $100.00K | $200.00K | +100.00% | |
| $1.30M | N/A | +550.00% | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $68.74 | |
| $50.04 | ||
| SMA 200 vs Price | -27.20% | |
| $76.50 | ||
| SMA 50 vs Price | +11.28% | |
| 1.02 | ||
| $4.81 | ||
| 39.28 | ||
| 58.05% | ||
| 120.83% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $200.00K | ||
| $116.58 | ||
| -$2.09M | ||
| -1,042.50% | ||
| -$331.45M | ||
| -165.72% | ||
| $1.69B | ||
| - | ||
| -$331.45M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 3.94 | ||
| 3.94 | ||
| -24.57 | ||
| - | ||
| 6.64 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 714.10 | ||
| 27.14 | ||
| -6.30 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $133.58M | ||
| $152.60M | ||
| $180.77M | ||
| $160.40M | ||
| $47.18M | ||
| $40.73M | ||
| $8.05M | ||
| $1.60M | ||
| $9.25M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $331.65M | ||
| $331.65M | ||
| $2.29M | ||
| $127.91M | ||
| $2.29M | ||
| $13.49M | ||
| $2,000.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$194.41M | ||
| -$2.60M | ||
| $71.68M | ||
| $2.60M | ||
| -$197.01M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JMP Securities | → | |
| JMP Securities | → | |
| Citizens Capital Markets | → | |
| JMP Securities | → | |
| JMP Securities | ||
| JMP Securities | → | |
| JMP Securities | → | |
| JMP Securities | → | |
| JMP Securities | ||
| JMP Securities |
Analyst sentiment
Institutional ownership
Screeners with INBX
FAQ
What is the ticker symbol for Inhibrx Biosciences, Inc.?
The ticker symbol for Inhibrx Biosciences, Inc. is NASDAQ:INBX
Does Inhibrx Biosciences, Inc. pay dividends?
No, Inhibrx Biosciences, Inc. does not pay dividends
What sector is Inhibrx Biosciences, Inc. in?
Inhibrx Biosciences, Inc. is in the Healthcare sector
What industry is Inhibrx Biosciences, Inc. in?
Inhibrx Biosciences, Inc. is in the Biotechnology industry
What country is Inhibrx Biosciences, Inc. based in?
Inhibrx Biosciences, Inc. is headquartered in United States
When did Inhibrx Biosciences, Inc. go public?
Inhibrx Biosciences, Inc. initial public offering (IPO) was on June 4, 2024
Is Inhibrx Biosciences, Inc. in the S&P 500?
No, Inhibrx Biosciences, Inc. is not included in the S&P 500 index
Is Inhibrx Biosciences, Inc. in the NASDAQ 100?
No, Inhibrx Biosciences, Inc. is not included in the NASDAQ 100 index
Is Inhibrx Biosciences, Inc. in the Dow Jones?
No, Inhibrx Biosciences, Inc. is not included in the Dow Jones index
When was Inhibrx Biosciences, Inc. last earnings report?
Inhibrx Biosciences, Inc.'s most recent earnings report was on November 14, 2025
When does Inhibrx Biosciences, Inc. report earnings?
The next expected earnings date for Inhibrx Biosciences, Inc. is March 16, 2026
Data Sources & References
- INBX Official Website inhibrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/2007919/000200791925000093/0002007919-25-000093-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/2007919/000200791925000019/0002007919-25-000019-index.htm
- INBX Profile on Yahoo Finance finance.yahoo.com/quote/INBX
- INBX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/inbx